10Sierra A, Luque M, Pontes C, et al. Long-term effectiveness and tolerability of a fixed dose combination enalapril plus nitrendipine in different hypertensive populations[J]. American Journal of Hypertension, 2005, 18 (5) : A54.
6Matsunaga N,Nakamura K, Yamamoto A,et al.Improvement by solid dispersion of the bi0availability of KRN633,a selective inhibitor of VEGF receptor-2 tyrosine kinase,and identification of its potential therapeutic window[J].Molecular Cancer Therapeutics,2006,5(1): 80-81.
7Pasut G,Veronese FM.State of the art in PEGylation: the great versatility achieved after forty years ofresearch[J].J Control. Release, 2012,161(2):461-472.
8Veronese FM,Mero A.The impact of PEGylation on biological therapies[J].Bio Drugs,2008,22(5):315-329.
9Barry P, Deanna DG.Permeability for Intestinal Absorption: Caeo-2 Assay and Related Issues [J].Current Drug Metabolism,2008,9(9): 893-900.
10Yutaka T, Hiromu K,Tatsuo Y, et al.Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs[J].Int J Pharm, 2002,246(1-2):85-94.
